Basics Guardant Health, Inc. IPO Date: October 1, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $7.5B Activated in VL: True Average Daily Range Avg Daily Range: $1.69 | 2.80% Avg Daily Range (30 D): $1.28 | 2.45% Avg Daily Range (90 D): $1.09 | 2.26% Institutional Daily Volume Avg Daily Volume: 1.28M Avg Daily Volume (30 D): 2.53M Avg Daily Volume (90 D): 2.1M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 7,442 Avg Inst. Trade: $3.09M Avg Inst. Trade (30 D): $3.29M Avg Inst. Trade (90 D): $3.31M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $6.49M Avg Closing Trade (30 D): $15.87M Avg Closing Trade (90 D): $13.77M Avg Closing Volume: 130.24K     News Aug 22, 2025 @ 1:00 PM Global Liquid Biopsy Market Set to Reach USD 7.05 ... Source: Marketsandmarkets Jul 31, 2025 @ 9:06 AM Guardant Health (GH) Q2 Revenue Up 31% Source: Jesterai Jul 25, 2025 @ 8:55 AM Minimal Residual Disease Testing Market Trends Ana... Source: Researchandmarkets.Com Jun 12, 2025 @ 8:58 AM Molecular Diagnostics for Cancer Market Research 2... Source: Researchandmarkets.Com Jun 3, 2025 @ 5:31 PM Epigenetics Market Anticipated to Achieve 11.8% CA... Source: Bcc Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.35 $-.8 $-.77 Diluted EPS $-3.35 $-.8 $-.77 Revenue $ 828.85M $ 232.09M $ 203.47M Gross Profit $ $ 150.88M $ 128.75M Net Income / Loss $ -413.82M $ -99.9M $ -95.16M Operating Income / Loss $ -460.75M $ -106.41M $ -111.04M Cost of Revenue $ $ 81.21M $ 74.72M Net Cash Flow $ -297.99M $ -68.37M $ 174.1M PE Ratio